INSIST

INSIST (In silico clinical trials for the treatment of acute ischemic stroke) is a European Union's Horizon 2020 research and innovation programme under grant agreement No 777072.  The main goal of INSIST is to realize in silico clinical stroke trials for biomedical products for treatment of acute ischemic stroke. Such an in silico clinical ischemic stroke trial consists of the generation of populations of virtual stroke patients, in silico models of treatments, and in silico models of the biophysiological aspects of the human response to stroke.
This channel reflects only the author's view and the European Commission is not responsible for any use that may be made of the information it contains.